Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Dr. Meltzer is studying molecular biomarkers that are able to identify Barrett’s Esophagus and indicate when a patient is likely to develop esophageal cancer.
More Articles on Gastroenterology:
8 Gastroenterology Devices Receive FDA 510(k) Clearance in March
ResearchMoz Releases Endosocpy Market Outlook Report
6 Steps to Keep GI-Driven Surgery Center Patients Safer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
